PRME
Price
$2.45
Change
+$0.29 (+13.43%)
Updated
Jun 24, 04:59 PM (EDT)
Capitalization
283.6M
43 days until earnings call
WHWK
Price
$1.92
Change
-$0.04 (-2.05%)
Updated
Jun 24, 04:59 PM (EDT)
Capitalization
98.46M
43 days until earnings call
Interact to see
Advertisement

PRME vs WHWK

Header iconPRME vs WHWK Comparison
Open Charts PRME vs WHWKBanner chart's image
Prime Medicine
Price$2.45
Change+$0.29 (+13.43%)
Volume$182.91K
Capitalization283.6M
Whitehawk Therapeutics
Price$1.92
Change-$0.04 (-2.05%)
Volume$1.63K
Capitalization98.46M
PRME vs WHWK Comparison Chart in %
Loading...
PRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WHWK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PRME vs. WHWK commentary
Jun 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRME is a Hold and WHWK is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 25, 2025
Stock price -- (PRME: $2.16 vs. WHWK: $1.95)
Brand notoriety: PRME and WHWK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PRME: 179% vs. WHWK: 97%
Market capitalization -- PRME: $283.6M vs. WHWK: $98.46M
PRME [@Biotechnology] is valued at $283.6M. WHWK’s [@Biotechnology] market capitalization is $98.46M. The market cap for tickers in the [@Biotechnology] industry ranges from $326.23B to $0. The average market capitalization across the [@Biotechnology] industry is $2.36B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PRME’s FA Score shows that 0 FA rating(s) are green whileWHWK’s FA Score has 0 green FA rating(s).

  • PRME’s FA Score: 0 green, 5 red.
  • WHWK’s FA Score: 0 green, 5 red.
According to our system of comparison, WHWK is a better buy in the long-term than PRME.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PRME’s TA Score shows that 6 TA indicator(s) are bullish while WHWK’s TA Score has 6 bullish TA indicator(s).

  • PRME’s TA Score: 6 bullish, 4 bearish.
  • WHWK’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both PRME and WHWK are a good buy in the short-term.

Price Growth

PRME (@Biotechnology) experienced а +44.00% price change this week, while WHWK (@Biotechnology) price change was -4.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.91%. For the same industry, the average monthly price growth was +35.46%, and the average quarterly price growth was +17.29%.

Reported Earning Dates

PRME is expected to report earnings on Aug 06, 2025.

WHWK is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+4.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRME($284M) has a higher market cap than WHWK($98.5M). PRME YTD gains are higher at: -26.027 vs. WHWK (-38.193). WHWK has higher annual earnings (EBITDA): 27.9M vs. PRME (-200M). WHWK has more cash in the bank: 231M vs. PRME (144M). WHWK has less debt than PRME: WHWK (0) vs PRME (121M). WHWK has higher revenues than PRME: WHWK (27.8M) vs PRME (3.85M).
PRMEWHWKPRME / WHWK
Capitalization284M98.5M288%
EBITDA-200M27.9M-717%
Gain YTD-26.027-38.19368%
P/E RatioN/A13.00-
Revenue3.85M27.8M14%
Total Cash144M231M62%
Total Debt121M0-
FUNDAMENTALS RATINGS
PRME vs WHWK: Fundamental Ratings
PRME
WHWK
OUTLOOK RATING
1..100
2320
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
46
Fair valued
PROFIT vs RISK RATING
1..100
10094
SMR RATING
1..100
9850
PRICE GROWTH RATING
1..100
4055
P/E GROWTH RATING
1..100
10034
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

WHWK's Valuation (46) in the Pharmaceuticals Major industry is in the same range as PRME (48) in the null industry. This means that WHWK’s stock grew similarly to PRME’s over the last 12 months.

WHWK's Profit vs Risk Rating (94) in the Pharmaceuticals Major industry is in the same range as PRME (100) in the null industry. This means that WHWK’s stock grew similarly to PRME’s over the last 12 months.

WHWK's SMR Rating (50) in the Pharmaceuticals Major industry is somewhat better than the same rating for PRME (98) in the null industry. This means that WHWK’s stock grew somewhat faster than PRME’s over the last 12 months.

PRME's Price Growth Rating (40) in the null industry is in the same range as WHWK (55) in the Pharmaceuticals Major industry. This means that PRME’s stock grew similarly to WHWK’s over the last 12 months.

WHWK's P/E Growth Rating (34) in the Pharmaceuticals Major industry is significantly better than the same rating for PRME (100) in the null industry. This means that WHWK’s stock grew significantly faster than PRME’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PRMEWHWK
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
77%
Momentum
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
74%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 5 days ago
79%
Declines
ODDS (%)
Bearish Trend 13 days ago
89%
Bearish Trend 20 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
PRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WHWK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DTEGY36.130.98
+2.79%
Deutsche Telekom AG
TORXF32.150.49
+1.55%
Torex Gold Resources, Inc.
KMTUY30.450.46
+1.53%
Komatsu Ltd.
BCBNF0.56N/A
N/A
Base Carbon Inc.
BKRIY13.23-0.07
-0.53%
Bank Ireland Group PLC

PRME and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRME has been loosely correlated with CRSP. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if PRME jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRME
1D Price
Change %
PRME100%
+4.35%
CRSP - PRME
63%
Loosely correlated
+2.94%
BEAM - PRME
57%
Loosely correlated
-0.30%
RXRX - PRME
56%
Loosely correlated
-3.78%
CRBU - PRME
53%
Loosely correlated
-1.49%
CCCC - PRME
52%
Loosely correlated
+3.52%
More

WHWK and

Correlation & Price change

A.I.dvisor indicates that over the last year, WHWK has been loosely correlated with AXON. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if WHWK jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WHWK
1D Price
Change %
WHWK100%
-6.70%
AXON - WHWK
44%
Loosely correlated
+0.76%
DMAC - WHWK
42%
Loosely correlated
+1.11%
IPSC - WHWK
38%
Loosely correlated
-1.19%
AMRN - WHWK
37%
Loosely correlated
+0.48%
FDMT - WHWK
37%
Loosely correlated
-7.82%
More